NCT06444542Completed
Understanding Patient Preference on Colorectal Cancer Screening Options-PSU
Understanding Patient Preference on Colorectal Cancer Screening Options
Source: ClinicalTrials.gov · Last updated 20 Feb 2026
Brief summary (registry, in English)
There are significant barriers to colorectal cancer screening within underserved populations due to the cost, accessibility, and acceptability of screening methods. Patient-friendly approaches that minimize stress and discomfort for the patient are needed to enhance screening compliance and achieve an early diagnosis. The primary aim of this study is to examine whether the availability of a blood-based screening option, which can be done at the point of service and is familiar to patients, will improve patient compliance to recommended CRC screening
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 297 (actual)
- First submitted
- 14 May 2024
- Start date
- 16 Sept 2024
- Primary completion date
- 18 Dec 2025
- Lead sponsor
- Milton S. Hershey Medical Center
- Diseases
- Colorectal cancer
- NCT number
- NCT06444542
What you commit to
- Study type: Observational
- Participants enrolled: 297
- From 16 Sept 2024 to the primary completion date, 18 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Personal History
- Participants who do not speak either Spanish or English
- History of CRC or adenoma
- History of cancers
- History of inflammatory bowel disease, including chronic ulcerative colitis and Crohn's disease
- Have a recorded up to date CRC screening
- Blood product transfusion in the past 120 days
- A medical condition which, in the opinion of the patient's health provider, should preclude enrollment in the study
Age
- Family history
- One first-degree relative diagnosed with CRC or advanced adenoma at age \<60 years
- Two first-degree relatives diagnosed with CRC or advanced adenoma at any age
- Known hereditary gastrointestinal cancer syndromes, such as Lynch Syndrome or Familial Adenomatous and Polyposis (FAP)
Other
- Participants will be excluded from enrolling in the study if they meet any of the following:
Who the study is looking for
- To be enrolled in this study, participants must meet all the following criteria:
- Between 45-75 years of age
- Language Proficiency: participants must be fluent in English or Spanish
- Have an average risk for colorectal cancer
- Be a patient at one of our partner FQHCs
- Received a screening order (either using a stool-based test or colonoscopy) six months ago and failed or refused to complete the screening test
- Able and willing to provide a blood sample per protocol
Age in the registry: 45 years to 75 years · Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Penn State College of Medicine Coordinator of this site? Confirm its status | Hershey | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.